Search

Your search keyword '"Temperli, Fabrice"' showing total 10 results
Start Over Author "Temperli, Fabrice" Search Limiters Full Text
10 results on '"Temperli, Fabrice"'

3. Computed Tomography Scan Evidence for Left Atrial Appendage Short‐Term Remodeling Following Percutaneous Occlusion: Impact of Device Oversizing

Author

Mahmoudi, Khalil, primary, Galea, Roberto, additional, Elhadad, Simon, additional, Temperli, Fabrice, additional, Sebag, Frederic, additional, Gräni, Christoph, additional, Rezine, Zhor, additional, Roten, Laurent, additional, Landolff, Quentin, additional, Brugger, Nicolas, additional, Masri, Alaa, additional, Räber, Lorenz, additional, and Amabile, Nicolas, additional

Published
2023
Full Text
View/download PDF

4. Impact of alirocumab on plaque regression and haemodynamics of non-culprit arteries in patients with acute myocardial infarction: a prespecified substudy of the PACMAN-AMI trial

Author

Bär, Sarah, primary, Kavaliauskaite, Raminta, additional, Otsuka, Tatsuhiko, additional, Ueki, Yasushi, additional, Häner, Jonas D., additional, Siontis, George C.M., additional, Stortecky, Stefan, additional, Shibutani, Hiroki, additional, Temperli, Fabrice, additional, Kaiser, Christoph, additional, Iglesias, Juan F., additional, Jan van Geuns, Robert, additional, Daemen, Joost, additional, Spirk, David, additional, Engstrøm, Thomas, additional, Lang, Irene, additional, Windecker, Stephan, additional, Koskinas, Konstantinos C., additional, Losdat, Sylvain, additional, and Räber, Lorenz, additional

Published
2023
Full Text
View/download PDF

5. Acute Coronary Occlusion in Patients With Non-ST-Segment Elevation Out-of-Hospital Cardiac Arrest

Author

Spirito, Alessandro, primary, Vaisnora, Lukas, additional, Papadis, Athanasios, additional, Iacovelli, Fortunato, additional, Sardu, Celestino, additional, Selberg, Alexandra, additional, Bär, Sarah, additional, Kavaliauskaite, Raminta, additional, Temperli, Fabrice, additional, Asatryan, Babken, additional, Pilgrim, Thomas, additional, Hunziker, Lukas, additional, Heg, Dik, additional, Valgimigli, Marco, additional, Windecker, Stephan, additional, and Räber, Lorenz, additional

Published
2023
Full Text
View/download PDF

6. TCT-8 Frequency, Predictors, and Impact of Acute Coronary Occlusion in Patients With Out-of-Hospital Cardiac Arrest and Non–ST-Segment Elevation

Author

Spirito, Alessandro, primary, Vaisnora, Lukas, additional, Papadis, Athanasios, additional, Iacovelli, Fortunato, additional, Sardu, Celestino, additional, Selberg, Alexandra, additional, Bär, Sarah, additional, Kavaliauskaite, Raminta, additional, Temperli, Fabrice, additional, Pilgrim, Thomas, additional, Hunziker, Lukas, additional, Heg, Dik, additional, Windecker, Stephan, additional, and Raber, Lorenz, additional

Published
2022
Full Text
View/download PDF

7. Comparative Outcomes After Percutaneous Coronary Intervention in Unconscious and Conscious Patients With Out-of-Hospital Cardiac Arrest

Author

Spirito, Alessandro, primary, Papadis, Athanasios, additional, Vaisnora, Lukas, additional, Iacovelli, Fortunato, additional, Sardu, Celestino, additional, Kavaliauskaite, Raminta, additional, Lanz, Jonas, additional, Temperli, Fabrice, additional, Asatryan, Babken, additional, Heg, Dik, additional, Hunziker, Lukas, additional, Windecker, Stephan, additional, Räber, Lorenz, additional, and Valgimigli, Marco, additional

Published
2022
Full Text
View/download PDF

8. Frequency, Reasons, and Impact of Premature Ticagrelor Discontinuation in Patients Undergoing Coronary Revascularization in Routine Clinical Practice

Author

Zanchin, Thomas, primary, Temperli, Fabrice, additional, Karagiannis, Alexios, additional, Zanchin, Christian, additional, Räsänen, Markus, additional, Koskinas, Konstantinos C., additional, Stortecky, Stefan, additional, Hunziker, Lukas, additional, Praz, Fabien, additional, Blöchlinger, Stefan, additional, Moro, Christina, additional, Moschovitis, Aris, additional, Seiler, Christian, additional, Billinger, Michael, additional, Heg, Dik, additional, Pilgrim, Thomas, additional, Valgimigli, Marco, additional, Windecker, Stephan, additional, and Räber, Lorenz, additional

Published
2018
Full Text
View/download PDF

9. Incidence, Predictors, and Clinical Impact of Early Prasugrel Cessation in Patients With ST‐Elevation Myocardial Infarction

Author

Koskinas, Konstantinos C., primary, Zanchin, Thomas, additional, Klingenberg, Roland, additional, Gencer, Baris, additional, Temperli, Fabrice, additional, Baumbach, Andreas, additional, Roffi, Marco, additional, Moschovitis, Aris, additional, Muller, Oliver, additional, Tüller, David, additional, Stortecky, Stefan, additional, Mach, Francois, additional, Lüscher, Thomas F., additional, Matter, Christian M., additional, Pilgrim, Thomas, additional, Heg, Dik, additional, Windecker, Stephan, additional, and Räber, Lorenz, additional

Published
2018
Full Text
View/download PDF

10. Incidence, Predictors, and Clinical Impact of Early Prasugrel Cessation in Patients With ST-Elevation Myocardial Infarction

Author

Koskinas, Konstantinos C, Zanchin, Thomas, Klingenberg, Roland, Gencer, Baris, Temperli, Fabrice, Baumbach, Andreas, Roffi, Marco, Moschovitis, Aris, Muller, Oliver, Tüller, David, Stortecky, Stefan, Mach, Francois, Lüscher, Thomas F, Matter, Christian M, Pilgrim, Thomas, Heg, Dik, Windecker, Stephan, Räber, Lorenz, Koskinas, Konstantinos C, Zanchin, Thomas, Klingenberg, Roland, Gencer, Baris, Temperli, Fabrice, Baumbach, Andreas, Roffi, Marco, Moschovitis, Aris, Muller, Oliver, Tüller, David, Stortecky, Stefan, Mach, Francois, Lüscher, Thomas F, Matter, Christian M, Pilgrim, Thomas, Heg, Dik, Windecker, Stephan, and Räber, Lorenz

Abstract

BACKGROUND Early withdrawal of recommended antiplatelet treatment with clopidogrel adversely affects prognosis following percutaneous coronary interventions. Optimal antiplatelet treatment is essential following ST-segment elevation myocardial infarction (STEMI) given the increased risk of thrombotic complications. This study assessed the frequency, predictors, and clinical impact of early prasugrel cessation in patients with STEMI undergoing primary percutaneous coronary interventions. METHODS AND RESULTS We pooled patients with STEMI discharged on prasugrel in 2 prospective registries (Bern PCI Registry [NCT02241291] and SPUM-ACS (Inflammation and Acute Coronary Syndromes) [NCT01000701]) and 1 STEMI trial (COMFORTABLE-AMI (Comparison of Biomatrix Versus Gazelle in ST-Elevation Myocardial Infarction) [NCT00962416]). Prasugrel treatment status at 1 year was categorized as no cessation; crossover to another P2Y-inhibitor; physician-recommended discontinuation; and disruption because of bleeding, side effects, or patient noncompliance. In time-dependent analyses, we assessed the impact of prasugrel cessation on the primary end point, a composite of cardiac death, myocardial infarction, and stroke. Of all 1830 included patients (17% women, mean age 59 years), 83% were treated with new-generation drug-eluting stents. At 1 year, any prasugrel cessation had occurred in 13.8% of patients including crossover (7.2%), discontinuation (3.7%), and disruption (2.9%). Independent predictors of any prasugrel cessation included female sex, age, and history of cerebrovascular event. The primary end point occurred in 5.2% of patients and was more frequent following disruption (hazard ratio 3.04, 95% confidence interval,1.34-6.91; =0.008), without significant impact of crossover or discontinuation. Consistent findings were observed for all-cause death, myocardial infarction, and stent thrombosis following prasugrel disruption. CONCLUSIONS In this contemporary study of patients with ST

Published
2018

Catalog

Books, media, physical & digital resources
See catalog results